Ethoxzolamide - CAS 452-35-7
Catalog number:
452-35-7
Category:
Inhibitor
Not Intended for Therapeutic Use. For research use only.
Molecular Formula:
C9H10N2O3S2
Molecular Weight:
258.31
COA:
Inquire
Targets:
Others
Description:
Ethoxzolamide is used in the treatment of glaucoma, and is also used as a diuretic, acting as a carbonic anhydrase inhibitor.
Publictions citing BOC Sciences Products
  • >> More
Purity:
≥98%
Appearance:
White to yellow powder
Synonyms:
6-ethoxy-2-benzothiazolesulfonamide;
Solubility:
Soluble in DMSO
Storage:
Store at -20 °C
MSDS:
Inquire
Application:
Acting as a carbonic anhydrase inhibitor.
Quality Standard:
Enterprise standard
Shelf Life:
As supplied, 2 years from the QC date provided on the Certificate of Analysis, when stored properly.
Quantity:
Milligrams-Grams
Density:
1.47g/cm3
InChIKey:
OUZWUKMCLIBBOG-UHFFFAOYSA-N
InChI:
1S/C9H10N2O3S2/c1-2-14-6-3-4-7-8(5-6)15-9(11-7)16(10,12)13/h3-5H,2H2,1H3,(H2,10,12,13)
Canonical SMILES:
CCOC1=CC2=C(C=C1)N=C(S2)S(=O)(=O)N
1.Comparison of the sulfonamide inhibition profiles of the α-, β- and γ-carbonic anhydrases from the pathogenic bacterium Vibrio cholerae.
Del Prete S1, Vullo D2, De Luca V3, Carginale V3, Osman SM4, AlOthman Z4, Supuran CT5, Capasso C6. Bioorg Med Chem Lett. 2016 Apr 15;26(8):1941-6. doi: 10.1016/j.bmcl.2016.03.014. Epub 2016 Mar 7.
Carbonic anhydrases (CA, EC 4.2.1.1) are ubiquitous metalloenzymes, which catalyze the conversion of carbon dioxide (CO2) to bicarbonate (HCO3(-)) and protons (H(+)). In prokaryotes, the existence of genes encoding for α-, β- and γ-classes suggests that these enzymes play an important role in the prokaryotic physiology. It has been demonstrated, in fact, that their inhibition in vivo leads to growth impairment or growth defects of the microorganism. Ultimately, we started to investigate the biochemical properties and the inhibitory profiles of the α- and β-CAs identified in the genome of Vibrio cholerae, which is the causative agent of cholera. The genome of this pathogen encodes for CAs belonging to α, β and γ classes. Here, we report a sulfonamide inhibition study of the γ-CA (named VchCAγ) comparing it with data obtained for the α- and β-CA enzymes. VchCAγ activity (kcat=7.39×10(5)s(-1)) was significantly higher than the other γ-CAs. The inhibition study with a panel of sulfonamides and one sulfamate led to the detection of a large number of nanomolar VchCAγ inhibitors, including simple aromatic/heterocyclic sulfonamides (compounds 2-9, 11, 13-15, 24) as well as EZA, DZA, BRZ, BZA, TPM, ZNS, SLP, IND (KIs in the range of 66.
2.Sulfonamide inhibition studies of the β-carbonic anhydrase from the pathogenic bacterium Vibrio cholerae.
Del Prete S1, Vullo D2, De Luca V3, Carginale V3, Ferraroni M2, Osman SM4, AlOthman Z4, Supuran CT5, Capasso C6. Bioorg Med Chem. 2016 Mar 1;24(5):1115-20. doi: 10.1016/j.bmc.2016.01.037. Epub 2016 Jan 22.
The genome of the pathogenic bacterium Vibrio cholerae encodes for three carbonic anhydrases (CAs, EC 4.2.1.1) belonging to the α-, β- and γ-classes. VchCA, the α-CA from this species was investigated earlier, whereas the β-class enzyme, VchCAβ was recently cloned, characterized kinetically and its X-ray crystal structure reported by this group. Here we report an inhibition study with sulfonamides and one sulfamate of this enzyme. The best VchCAβ inhibitors were deacetylated acetazolamide and methazolamide and hydrochlorothiazide, which showed inhibition constants of 68.2-87.0nM. Other compounds, with medium potency against VchCAβ, (KIs in the range of 275-463nM), were sulfanilamide, metanilamide, sulthiame and saccharin whereas the clinically used agents such as acetazolamide, methazolamide, ethoxzolamide, dorzolamide, zonisamide and celecoxib were micromolar inhibitors (KIs in the range of 4.51-8.57μM). Identification of potent and possibly selective inhibitors of VchCA and VchCAβ over the human CA isoforms, may lead to pharmacological tools useful for understanding the physiological role(s) of this under-investigated enzymes.
3.Sulfonamide inhibition studies of the α-carbonic anhydrase from the gammaproteobacterium Thiomicrospira crunogena XCL-2, TcruCA.
Vullo D1, Bhatt A2, Mahon BP2, McKenna R2, Supuran CT3. Bioorg Med Chem Lett. 2016 Jan 15;26(2):401-5. doi: 10.1016/j.bmcl.2015.11.104. Epub 2015 Dec 1.
We report a sulfonamide/sulfamate inhibition study of the α-carbonic anhydrase (CA, EC 4.2.1.1) present in the gammaproteobacterium Thiomicrospira crunogena XCL-2, a mesophilic hydrothermal vent-isolate organism, TcruCA. As Thiomicrospira crunogena is one of thousands of marine organisms that uses CA for metabolic regulation, the effect of sulfonamide inhibition has been considered. Sulfonamide-based drugs have been widely used in a variety of antibiotics, and bioelimination of these compounds results in exposure of these compounds to marine life. The enzyme was highly inhibited, with Ki values ranging from 2.5 to 40.7nM by a variety of sulfonamides including acetazolamide, methazolamide, ethoxzolamide, dichlorophenamide, dorzolamide, brinzolamide, benzolamide and benzenesulfonamides incorporating 4-hydroxyalkyl moieties. Less effective inhibitors were topiramate, zonisamide, celecoxib, saccharin and hydrochlorothiazide as well as simple benzenesulfonamides incorporating amino, halogeno, alkyl, aminoalkyl and other moieties in the ortho- or para-positions of the aromatic ring (Kis of 202-933nM).
4.Intrinsic thermodynamics of trifluoromethanesulfonamide and ethoxzolamide binding to human carbonic anhydrase VII.
Pilipuitytė V1, Matulis D. J Mol Recognit. 2015 Mar;28(3):166-72. doi: 10.1002/jmr.2404. Epub 2015 Feb 3.
Human carbonic anhydrase (CA) isozyme VII is a cytosolic protein that is highly expressed in the cortex, hippocampus, and thalamus regions within mammalian brain, and expression disorders can cause epilepsy and several cases of malignant brain tumors. Therefore, CA VII is a potential antiepileptic and anticancer drug target. There are numerous sulfonamides that target CAs nonspecifically. It is important to understand the thermodynamics of inhibitor binding and the structural features of the protein-inhibitor complex in order to design specific inhibitors against CA VII. Isothermal titration calorimetry and fluorescent thermal shift assay were used to characterize the intrinsic thermodynamic parameters of trifluoromethanesulfonamide and ethoxzolamide binding to CA VII. Binding experiments were carried out at various pH in different buffers in order to dissect linked protonation of the water molecule bound to the CA VII active site, deprotonation of the sulfonamide group of the inhibitor, and protonation-deprotonation of buffer.
Molecular Weight Calculator Molarity Calculator Solution Dilution Calculator

Related Products


CAS 223445-75-8 Atagabalin

Atagabalin
(CAS: 223445-75-8)

Atagabalin, also referred to PD-0200,390, is a gabamimetic agent developed as a treatment for insomnia but was discontinued following unsatisfactory trial resul...

CAS 126643-37-6 KT 5823

KT 5823
(CAS: 126643-37-6)

KT 5823 is a cell-permeable, selective inhibitor of cGMP-dependent protein kinase (PKG) (Ki values are 0.23, 4 and > 10 μM for inhibition of PKG, PKC and PKA re...

CAS 107-35-7 Taurine

Taurine
(CAS: 107-35-7)

Taurine is an organic acid widely distributed in animal tissues.

CAS 549-18-8 Amitriptyline Hydrochloride

Amitriptyline Hydrochloride
(CAS: 549-18-8)

Amitriptyline inhibits serotonin receptor, norepinephrine receptor, 5-HT4, 5-HT2 and sigma 1 receptor with IC50 of 3.45 nM, 13.3 nM, 7.31 nM, 235 nM and 287 nM,...

CAS 3759-92-0 Furaltadone Hydrochloride

Furaltadone Hydrochloride
(CAS: 3759-92-0)

Furaltadone HCl is an antibacterial and has distinct curative effect in the treatment of coccidiosis.

PD 130908
(CAS: 131505-02-7)

PD 130908 is an effective hypoxic cytotoxin as an analogue of RSU 1069, but less potent than the hypoxic cell radiosensitizer RSU 1069. Toxicity toward hypoxic ...

AF38469
(CAS: 1531634-31-7)

AF38469 is a novel, selective, orally bioavailable Sortilin inhibitor and showed no inhibition or stimulation of >50% at 10μM in a standard selectivity panel of...

CAS 55837-20-2 Halofuginone

Halofuginone
(CAS: 55837-20-2)

Halofuginone is a semisynthetic quinazolinone alkaloid anticoccidial derived from the plant Dichroa febrifuga, with antifibrotic and potential antineoplastic ac...

CAS 1093069-32-9 JNJ-39327041

JNJ-39327041
(CAS: 1093069-32-9)

JNJ-39327041 is a bio-active chemical compound.

CAS 554435-83-5 Deferasirox Fe3(addition) chelate

Deferasirox Fe3(addition) chelate
(CAS: 554435-83-5)

Deferasirox Fe3+ chelate is a rationally-designed oral iron chelator. Its main use is to reduce chronic iron overload in patients who are receiving long-term bl...

CAS 27314-97-2 Tirapazamine

Tirapazamine
(CAS: 27314-97-2)

Tirapazamine is a benzotriazine di-N-oxide with potential antineoplastic activity. Tirapazamine is selectively activated by multiple reductases to form free rad...

CAS 616-91-1 Acetylcysteine

Acetylcysteine
(CAS: 616-91-1)

Acetylcysteine is used mainly as a mucolytic, protects against acetaminophen overdose-induced hepatotoxicity by maintaining or restoring hepatic concentrations ...

CAS 444932-31-4 TC-O9311

TC-O9311
(CAS: 444932-31-4)

TC-O9311 is a potent, selective agonist of GPR139 (EC50 = 39 nM in CHO-K1 cells expressing human GPR139) with no activity against a range of 90 diverse targets.

CAS 87-99-0 Xylitol

Xylitol
(CAS: 87-99-0)

Xylitol is a chemical categorized as a polyalcohol or sugar alcohol (alditol). It is an achiral isomer of pentane-1,2,3,4,5-pentol. It is used as a diabetic swe...

CAS 4474-91-3 Angiotensin II

Angiotensin II
(CAS: 4474-91-3)

Angiotensin II is an endogenous potent vasoconstrictor peptide typically generated by the removal of two residues from angiotensin I by angiotensin-converting e...

CAS 329216-63-9 Quetiapine metabolite Quetiapine sulfoxide

Quetiapine metabolite Quetiapine sulfoxi
(CAS: 329216-63-9)

Quetiapine metabolite Quetiapine sulfoxide, a metabolite of Quetiapine, has antipsychotic effect.

CAS 541-46-8 Isovaleramide

Isovaleramide
(CAS: 541-46-8)

Isovaleramide is an anticonvulsant molecule isolated from Valeriana pavonii, it inhibits the liver alcohol dehydrogenases.

CAS 1786-81-8 Prilocaine hydrochloride

Prilocaine hydrochloride
(CAS: 1786-81-8)

Prilocaine hydrochloride is a local anesthetic of the amino amide type.

CAS 98753-19-6 Cefpirome Sulfate

Cefpirome Sulfate
(CAS: 98753-19-6)

Cefpirome Sulfate is a fourth generation cephalosporin antibiotic. It was developed by German company Hoechst and France Roussel company together.

CAS 90098-04-7 Rebamipide

Rebamipide
(CAS: 90098-04-7)

Rebamipide has been shown to enhance mucosal defense by scavenging free radicals, and temporarily activating genes encoding cyclooxygenase-2.

Chemical Structure

CAS 452-35-7 Ethoxzolamide

Quick Inquiry

Verification code

Featured Items